Prooxidants May Fix Metabolic Defect in Arthritis-Driving T Cells *free* (1 of 1) (IMAGE)

American Association for the Advancement of Science (AAAS)

Prooxidants May Fix Metabolic Defect in Arthritis-Driving T Cells *free* (1 of 1)

Caption

Rheumatoid arthritis is a common autoimmune disease involving joint inflammation and damage. Researchers have uncovered a metabolic defect in T cells from rheumatoid arthritis patients, which may be corrected by replenishing T cells' reactive oxygen species supply. This material relates to a paper that appeared in the March, 23, 2016 issue of <i>Science Translational Medicine</i>, published by AAAS. The paper, by author at institution in location, and colleagues was titled, "Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis."

Credit

V. Altounian / <i>Science Translational Medicine</i> (2016)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.